Vital capacity and selected metabolic diseases in middle-aged Japanese men

Canadian Respiratory Journal

Volumn 13, Issue 2, 2006, Pages 79-82

  Sakuta, Hidenari ^a,b   Suzuki, Takashi ^a   Yasuda, Hiroko ^a   Ito, Teizo ^a  

^a Self Defense Forces Central Hospital   (Japan)

^b Ground Self Defense Force Medical School   (Japan)

Author keywords

Diabetes; Gamma glutamyl transferase; Triglyceride; Vital capacity

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FORCED EXPIRATORY VOLUME; GROUPS BY AGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTRIGLYCERIDEMIA; JAPAN; LIFESTYLE; LINEAR REGRESSION ANALYSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL HEALTH; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VITAL CAPACITY;

EID: 33645923107     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/892034     Document Type: Article

References (31)

1. Neas LM, Schwartz J. Pulmonary function levels as predictors of mortality in a national sample of US adults. Am J Epidemiol 1998;147:1011-8.
2. Keys A, Aravanis C, Blackburn H, et al. Lung function as a risk factor for coronary heart disease. Am J Public Health 1972;62:1506-11.
3. Friedman GD, Klatsky AL, Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976;294:1071-5.
4. Engstrom G, Hedblad B, Valind S, Janzon L. Asymptomatic leg and carotid atherosclerosis in smokers is related to degree of ventilatory capacity: Longitudinal and cross-sectional results from 'Men born in 1914', Sweden. Atherosclerosis 2001;155:237-43.
5. Engstrom G, Janzon L. Risk of developing diabetes is inversely related to lung function: A population-based cohort study. Diabet Med 2002;19:167-70.
6. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and type 2 diabetes: Findings from the British Women's Heart and Health Study. Diabetologia 2004;47:195-203.
7. Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: A longitudinal cohort study. J Intern Med 2003;253:574-81.
8. Engstrom G, Wollmer P, Valind S, Hedblad B, Janzon L. Blood pressure increase between 55 and 68 years of age is inversely related to lung function: Longitudinal result from the cohort study 'Men born in 1914'. J Hypertens 2001;19:1203-8.
9. Wu Y, Vollmer WM, Buist AS, et al; PRC-USA Cardiovascular and Cardiopulmonary Epidemiology Research Group. Relationship between lung function and blood pressure in Chinese men and women of Beijing and Guangzhou. Int J Epidemiol 1998;27:49-56.
10. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 2005;28:1472-9.
11. Zureik M, Liard R, Kauffmann F, Henry C, Neukirch F. Alcohol consumption, gamma-glutamyl transpeptidase (GGT), and pulmonary function: A cross-sectional and longitudinal study in working men. Alcohol Clin Exp Res 1996;20:1507-11.
12. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: Determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995;142:699-708.
13. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355.
14. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992;267:1253-6.
15. Hackam DG, Peterson JC, Spence JD. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L. Am J Hypertens 2000;13:105-10.
16. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995;41:991-4.
17. Baldwin ED, Cournand A, Richards DW Jr. Pulmonary insufficiency. I. Physiological classification, clinical methods of analysis, standard values in normal subjects. Medicine 1948;27:243-78.
18. Brevik A, Vollset SE, Tell GS, et al. Plasma concentration of folate as a biomarker for the intake of fruit and vegetables: The Hordaland Homocysteine Study. Am J Clin Nutr 2005;81:434-9.
19. World Health Organization Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO, 1999.
20. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289:2560-72. (Erratum in 2003;290:197).
21. Engstrom G, Lind P, Hedblad B, et al. Lung function and cardiovascular risk: Relationship with inflammation-sensitive plasma proteins. Circulation 2002;106:2555-60.
22. Lange P, Parner J, Schonohr P, Jensen G. Copenhagen City Heart Study: Longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J 2002;20:1406-12.
23. Lazarus R, Sparrow D, Weiss ST. Impaired ventilatory function and elevated insulin levels in nondiabetic males: The Normative Aging Study. Eur Respir J 1998;12:635-40.
24. Lazarus R, Sparrow D, Weiss ST. Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: The Normative Aging Study. Eur Respir J 1998;12:641-5.
25. Cooper KH, Pollock ML, Martin RP, White SR, Linnerud AC, Jackson A. Physical fitness levels vs selected coronary risk factors. A cross-sectional study. JAMA 1976;236:166-9.
26. Samet JM, Hatch GE, Horstman D, et al. Effect of antioxidant supplementation on ozone-induced lung injury in human subjects. Am J Respir Crit Care Med 2001;164:819-25.
27. Lazarus R, Gore CJ, Booth M, Owen N. Effects of body composition and fat distribution on ventilatory function in adults. Am J Clin Nutr 1998;68:35-41.
28. Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: The normative aging study. Chest 1997;111:891-8.
29. Bray GA. Complications of obesity. Ann Intern Med 1985;103:1052-62.
30. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004;38:535-9.
31. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998;21:732-7.